4.8 Article

N-terminal degradation activates the NLRP1B inflammasome

Journal

SCIENCE
Volume 364, Issue 6435, Pages 82-+

Publisher

AMER ASSOC ADVANCEMENT SCIENCE
DOI: 10.1126/science.aau1208

Keywords

-

Funding

  1. Josie Robertson Foundation
  2. Stand Up to Cancer-Innovative Research Grant [SU2C-AACR-IRG11-17]
  3. Stand Up to Cancer is a program of the Entertainment Industry Foundation
  4. Pew Charitable Trusts
  5. NIH [R01 AI137168, T32 GM007739, T32 GM115327, P30 CA008748]
  6. Alfred P. Sloan Foundation Research Fellowship
  7. American Cancer Society [PF-17-224-01 - CCG]
  8. Gabrielle's Angel Foundation

Ask authors/readers for more resources

Intracellular pathogens and danger signals trigger the formation of inflammasomes, which activate inflammatory caspases and induce pyroptosis. The anthrax lethal factor metalloprotease and small-molecule DPP8/9 inhibitors both activate the NLRP1B inflammasome, but the molecular mechanism of NLRP1B activation is unknown. In this study, we used genome-wide CRISPR-Cas9 knockout screens to identify genes required for NLRP1B-mediated pyroptosis. We discovered that lethal factor induces cell death via the N-end rule proteasomal degradation pathway. Lethal factor directly cleaves NLRP1B, inducing the N-end rule-mediated degradation of the NLRP1B N terminus and freeing the NLRP1B C terminus to activate caspase-1. DPP8/9 inhibitors also induce proteasomal degradation of the NLRP1B N terminus but not via the N-end rule pathway. Thus, N-terminal degradation is the common activation mechanism of this innate immune sensor.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available